Navigation Links
Diplomat Specialty Pharmacy Health Services Division Achieves High Marks in Pilot Program for Chronic Kidney Disease Management

SWARTZ CREEK, Mich., Oct. 17 /PRNewswire/ -- Diplomat Health Services, in conjunction with McLaren Health Plan, The National Kidney Foundation of Michigan, and corporate sponsor Genzyme, announced today the results of its pilot program for the management of Chronic Kidney Disease (CKD). The program managed chronic kidney disease patients for McLaren Health Plan and showed combined medication and medical cost savings of $300 per patient per month compared to the control group.

Ron Alexander, Vice President of Clinical Services, stated, "This proactive approach proves the effectiveness of our Disease Management Program. We further validated the published savings of $150 per patient per day in delaying the onset of dialysis. Kudos to our staff who received excellent results from our patient satisfaction surveys. Obviously we are very pleased with these results."

The program developed over the course of one year included disease management for Chronic Kidney Disease, Diabetes, and Hypertension. The heart of the CKD Navigator Program is Diplomat's clinical staff who consulted with the patient and their primary care physician to assist in the care of the patient. Medical and prescription cost data was tracked for 6 months and compared to a control group. The program will now be expanded to include additional patients.

Dr. Petroff, Medical Director, McLaren Health Plan stated, "We know disease management programs benefit both patients and healthcare professionals. The results of this CKD pilot program prove that a well-managed CKD disease management program can make a difference in the health of people living with this disease. This data proves that when patients are personally coached or managed, they become more adherent in taking their medication and have a more positive response to therapy."

Maurie Ferriter, Director of Programs and Services at the National Kidney Foundation of Michigan stated, "This shows that this is truly a win - win situation for patients and providers. Providers save money in the management of people with CKD and the individuals with CKD have a better medical outcome and quality of life."

About Diplomat Specialty Pharmacy

Diplomat Specialty Pharmacy is a privately held health care organization focusing on complete medication management programs for patients with serious and chronic conditions. Key programs include: Oncology, HIV/AIDS, Hepatitis C, Multiple Sclerosis, Rheumatoid Arthritis and Psoriasis. Other specialty areas include Transplant, Fertility, Dialysis Medication Management, Bio- Identical Hormone Replacement Therapy and Specialty Compounding. The company's Health Services division specializes in Disease Management programs for Chronic Kidney Disease patients, as well as Home Infusion and operates infusion suites. "With locations in Flint and Grand Rapids, MI; Cleveland, OH; Chicago, IL; and Ft. Lauderdale, FL; Diplomat services the specialty pharmacy needs of patients and physicians nationwide."

For more information contact:

Alecia Greilich - Director of Payor Relations


SOURCE Diplomat Specialty Pharmacy
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. Charter and Berbee connect Pharmacy Cooperative
2. Bio-Plex Cytokine Immunoassays and ELISA: Comparison of Two Methodologies in Testing Samples From Asthmatic and Healthy Children, Rev A
3. Web-based reporting credited with states top healthcare ranking
4. Visions, Part II: Preizler sees IT leading incremental health system change
5. Visions: Preizler offers insurers perspective on healthcare IT
6. Federal bill would set healthcare IT standards
7. IRS ruling could speed healthcare technology adoption
8. Bill would provide federal aid for healthcare IT
9. Cardinal Health likes growth potential of Viasys NeuroCare Group
10. DHC 2007: Controlling health IT costs the key to capturing value
11. Siemens health services president calls IT benefits unassailable
Post Your Comments:
(Date:11/25/2015)... Nov. 25, 2015 /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ: ... business and prospects remain fundamentally strong and highlights ... doxorubicin) recently received DSMB recommendation to continue the ... review of the final interim efficacy and safety ... Endpoint in men with heavily pretreated castration- and ...
(Date:11/25/2015)... SAN DIEGO , Nov. 25, 2015 ... that management will participate in a fireside chat discussion ... New York . The discussion is ... Time. .  A replay will ... Contact:  Media Contact:McDavid Stilwell  , Julie NormartVP, Corporate ...
(Date:11/25/2015)... Francisco, CA (PRWEB) , ... November 25, 2015 ... ... microbial genomics company uBiome, were featured on AngelList early in their initial angel ... launching an AngelList syndicate for individuals looking to make early stage investments in ...
(Date:11/24/2015)... ... November 24, 2015 , ... The United States Golf Association ... 2016 USGA Green Section Award. Presented annually since 1961, the USGA Green Section Award ... work with turfgrass. , Clarke, of Iselin, N.J., is an extension specialist ...
Breaking Biology Technology:
(Date:11/11/2015)... , Nov. 11, 2015   MedNet Solutions , an ... of clinical research, is pleased to announce that it will ... Trials (PCT) event, to be held November 17-19 in ... to view live demonstrations of iMedNet , ... how iMedNet has been able to deliver time ...
(Date:11/10/2015)... , Nov. 10, 2015 ... behavioral biometrics that helps to identify and verify ... Signature is considered as the secure and accurate ... identification of a particular individual because each individual,s ... accurate results especially when dynamic signature of an ...
(Date:11/9/2015)... SAN JOSE, Calif. , Nov. 9, 2015 /PRNewswire/ ... of human interface solutions, today announced broader entry into ... of vehicle-specific solutions that match the pace of consumer ... drivers, and biometric sensors are ideal for the automotive ... the vehicle. Europe , ...
Breaking Biology News(10 mins):